AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PREMIER MITON GROUP PLC

Declaration of Voting Results & Voting Rights Announcements Jun 1, 2018

7855_rns_2018-06-01_00b1c13d-b3ef-4278-bb06-82aff0c5cc68.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0801Q

Miton Group Plc

01 June 2018

1 June 2018

MITON GROUP PLC ("the Company")

TREASURY SHARES

Miton Group plc ('MGR'), the AIM quoted fund management company, announces that today it has transferred 16,726 ordinary shares of 0.1 pence each in the Company from Treasury to the underlying holder under the terms of a deferred payment scheme (the 'Transfer').

Following this Transfer, the Company holds no shares in Treasury.

Total Voting Rights

The Company's issued share capital comprises 172,635,411 shares. Following the Transfer, the total voting rights of the Company comprises 172,635,411 shares and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

END

For further information, please contact:

Miton Group plc

Catriona Fletcher (Company Secretary)                     020 3714 1500

Peel Hunt (Nominated adviser and Broker)          

Guy Wiehahn                                                              020 7418 8893

www.mitongroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

POSUAASRWSANRAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.